We constructed nomograms using selected variables—β2MG, platelet, albumin, and SUVmax—to predict early OS rates at 6-month and 1-year OS for patients with AITL (Figure 2). This evidence concerns the gene ALB and angioimmunoblastic T-cell lymphoma.